FUSN Annual EBIT
-$88.94 M
-$1.30 M-1.48%
31 December 2023
Summary:
As of February 5, 2025, FUSN annual earnings before interest & taxes is -$88.94 million, with the most recent change of -$1.30 million (-1.48%) on December 31, 2023. During the last 3 years, it has fallen by -$51.01 million (-134.46%).FUSN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN Quarterly EBIT
-$32.05 M
-$6.51 M-25.47%
31 March 2024
Summary:
As of February 5, 2025, FUSN quarterly earnings before interest & taxes is -$32.05 million, with the most recent change of -$6.51 million (-25.47%) on March 31, 2024. Over the past year, it has dropped by -$15.88 million (-98.11%).FUSN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN TTM EBIT
-$97.92 M
-$8.98 M-10.09%
31 March 2024
Summary:
As of February 5, 2025, FUSN TTM earnings before interest & taxes is -$97.92 million, with the most recent change of -$8.98 million (-10.09%) on March 31, 2024. Over the past year, it has dropped by -$10.73 million (-12.31%).FUSN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FUSN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.5% | -98.1% | -12.3% |
| 3 y3 years | -134.5% | -98.1% | -12.3% |
| 5 y5 years | -810.9% | -98.1% | -12.3% |
FUSN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +1177.4% | +729.6% | +442.7% |
Fusion Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$32.05 M(+25.5%) | -$97.92 M(+10.1%) |
| Dec 2023 | -$88.94 M(+1.5%) | -$25.55 M(+57.9%) | -$88.94 M(+2.0%) |
| Sept 2023 | - | -$16.18 M(-33.0%) | -$87.19 M(-8.6%) |
| June 2023 | - | -$24.14 M(+4.6%) | -$95.40 M(+5.1%) |
| Mar 2023 | - | -$23.08 M(-3.0%) | -$90.76 M(+3.6%) |
| Dec 2022 | -$87.65 M(+8.0%) | -$23.79 M(-2.5%) | -$87.65 M(+8.8%) |
| Sept 2022 | - | -$24.39 M(+25.1%) | -$80.56 M(+6.4%) |
| June 2022 | - | -$19.50 M(-2.3%) | -$75.69 M(-9.3%) |
| Mar 2022 | - | -$19.96 M(+19.5%) | -$83.45 M(+2.8%) |
| Dec 2021 | -$81.17 M(+114.0%) | -$16.70 M(-14.4%) | -$81.17 M(+6.5%) |
| Sept 2021 | - | -$19.52 M(-28.4%) | -$76.20 M(+13.8%) |
| June 2021 | - | -$27.27 M(+54.2%) | -$66.96 M(+42.6%) |
| Mar 2021 | - | -$17.68 M(+50.6%) | -$46.96 M(+23.8%) |
| Dec 2020 | -$37.94 M | -$11.74 M(+14.2%) | -$37.94 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$10.28 M(+41.6%) | -$32.29 M(+23.6%) |
| June 2020 | - | -$7.26 M(-16.1%) | -$26.13 M(+14.9%) |
| Mar 2020 | - | -$8.66 M(+42.0%) | -$22.73 M(+26.0%) |
| Dec 2019 | -$18.04 M(+84.8%) | -$6.10 M(+48.1%) | -$18.04 M(-53.6%) |
| Sept 2019 | - | -$4.12 M(+6.5%) | -$38.91 M(-64.6%) |
| June 2019 | - | -$3.86 M(-2.6%) | -$109.83 M(-11.0%) |
| Mar 2019 | - | -$3.97 M(-85.3%) | -$123.42 M(-20.1%) |
| Dec 2018 | -$9.76 M(+39.8%) | - | - |
| Dec 2018 | - | -$26.96 M(-64.1%) | -$154.55 M(-2.8%) |
| Sept 2018 | - | -$75.03 M(+330.0%) | -$159.00 M(+41.0%) |
| June 2018 | - | -$17.45 M(-50.3%) | -$112.77 M(+18.3%) |
| Mar 2018 | - | -$35.10 M(+11.7%) | -$95.32 M(+58.3%) |
| Dec 2017 | -$6.99 M | - | - |
| Dec 2017 | - | -$31.42 M(+9.1%) | -$60.22 M(+109.1%) |
| Sept 2017 | - | -$28.80 M | -$28.80 M |
FAQ
- What is Fusion Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals annual EBIT year-on-year change?
- What is Fusion Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals quarterly EBIT year-on-year change?
- What is Fusion Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Fusion Pharmaceuticals?
- What is Fusion Pharmaceuticals TTM EBIT year-on-year change?
What is Fusion Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of FUSN is -$88.94 M
What is the all time high annual EBIT for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high annual earnings before interest & taxes is -$6.96 M
What is Fusion Pharmaceuticals annual EBIT year-on-year change?
Over the past year, FUSN annual earnings before interest & taxes has changed by -$1.30 M (-1.48%)
What is Fusion Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of FUSN is -$32.05 M
What is the all time high quarterly EBIT for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$3.86 M
What is Fusion Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, FUSN quarterly earnings before interest & taxes has changed by -$15.88 M (-98.11%)
What is Fusion Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of FUSN is -$97.92 M
What is the all time high TTM EBIT for Fusion Pharmaceuticals?
Fusion Pharmaceuticals all-time high TTM earnings before interest & taxes is -$18.04 M
What is Fusion Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, FUSN TTM earnings before interest & taxes has changed by -$10.73 M (-12.31%)